Chronic Kidney Disease Trial, Recruiting NCT07047547 Sponsor: Guangdong Provincial People's Hospital Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07047547
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old.
  • You have been diagnosed with chronic kidney disease, meaning your kidneys are not filtering blood at full capacity.
  • You have chronic heart failure with a weakened heart pump (your heart is pumping at 50% or less of its normal capacity), and your symptoms are at a moderate level or worse.
  • Your blood potassium level has been at or below 4.8 mmol/L in the past month.
  • If you are a woman who could become pregnant, you had a negative pregnancy test at your first study visit and agreed to use reliable birth control during the trial.
  • Your dialysis is working well enough, as measured by specific tests your care team will check (confirm with trial site).
  • You have agreed to take part voluntarily, and the study has been approved by a hospital ethics committee.

Who may not be able to join:

  • You are currently experiencing sudden or acute kidney failure.
  • Your blood pressure is too low (below 90 mmHg systolic at screening, or below 95 mmHg between dialysis sessions).
  • Your breathing problems are caused mainly by a lung condition rather than heart failure, or you have right-sided heart failure caused by a lung disease.
  • You have had a heart attack or stroke within the past 3 months.
  • You have a history of a serious allergic reaction causing sudden swelling (angioedema).
  • You are on haemodialysis fewer than 3 times per week.
  • Your blood test results at screening show significant abnormalities, such as potassium levels that are too high or too low, very low sodium, or signs of liver strain (confirm with trial site).
  • You have had a kidney transplant in the past, or you are planning to have one within the next 12 months.
  • You are taking certain medications used to treat a lung blood pressure condition, such as sildenafil, during the study period.
  • You have a known allergy to the study treatment or any of its ingredients.
  • You have another serious illness, such as active cancer, or a condition that means you are not expected to live for at least 12 months.
  • You are currently pregnant or breastfeeding, or you plan to become pregnant during the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shuangxin Liu, Guangdong Provincial People's Hospital

Phone: (+86)020-83525210

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Left ventricular ejection fraction(LVEF); Left ventricular ejection fraction (LVEF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov